Bioventix PLC
BVXP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £6 | £7 | £7 | £7 |
| % Growth | -5.2% | -2.9% | 3.8% | – |
| Cost of Goods Sold | £0 | £1 | £1 | £0 |
| Gross Profit | £6 | £6 | £6 | £6 |
| % Margin | 92.6% | 87.8% | 92.4% | 93.2% |
| R&D Expenses | £0 | £0 | £1 | £0 |
| G&A Expenses | £0 | £1 | £1 | £1 |
| SG&A Expenses | £1 | £1 | £1 | £1 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | -£0 | -£1 | -£0 |
| Operating Expenses | £1 | £1 | £1 | £1 |
| Operating Income | £5 | £5 | £5 | £5 |
| % Margin | 77.1% | 72.1% | 78.7% | 77.1% |
| Other Income/Exp. Net | -£0 | £0 | -£0 | £0 |
| Pre-Tax Income | £5 | £5 | £5 | £5 |
| Tax Expense | £1 | £1 | £1 | £1 |
| Net Income | £4 | £4 | £4 | £4 |
| % Margin | 59.7% | 56% | 58.8% | 60.3% |
| EPS | 0.73 | 0.72 | 0.78 | 0.77 |
| % Growth | 1.4% | -7.7% | 1.3% | – |
| EPS Diluted | 0.72 | 0.71 | 0.78 | 0.76 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £5 | £5 | £5 | £5 |
| % Margin | 77.6% | 73.4% | 78% | 78.2% |